Telesis Bio (NASDAQ:TBIO) just reported results for the first quarter of 2024.
- Telesis Bio reported earnings per share of -$5.52. This was below the analyst estimate for EPS of -$4.14.
- The company reported revenue of $3.44 million.
- This was 50.14% worse than the analyst estimate for revenue of $6.90 million.